At the time of initiation of biologic therapy, 7.0% (114/1640) of patients had low BSA involvement, 46.9% (769/1640) had medium BSA involvement, and 46.2% (757/1640) had high BSA involvement
View Study [2]"Effects of low-dose growth hormone treatment on obesity: a meta-analysis of randomized controlled trials" Sun F, Yang A, Jin Y, et al., 2025 Finding: This meta-analysis of 10 randomized trials found that low-dose HGH therapy significantly reduces visceral (belly) fat and increases thigh muscle mass in obese individuals
GST gene polymorphisms have been identified and produce an important impact in enzyme activity
Headache or fatigue: Some users report transient symptoms, though these are not consistently observed in trials
No waiting rooms, no driving to clinics, no wasted time
As drug levels decline, appetite suppression weakens progressively